How to Talk to Your Patient

Prostate cancer patient and urologist 

It can be overwhelming for patients to remember all the information they are told during an office visit. Download resources that may be helpful in discussing prostate cancer and genomic testing with your patients.

Oncotype DX Genomic Prostate Score (GPS)

  • A genomic test measures the expression of genes within a sample of tumor tissue. The Oncotype DX GPS test is a genomic test, and the results can help determine how aggressive the patient’s cancer is.
  • For patients who have been recently diagnosed with low- or intermediate-risk prostate cancer and have not yet begun treatment, the Oncotype DX GPS might be appropriate to help guide management decisions. The GPS is not intended for men with advanced prostate cancer.

Preparing for test results

 

Oncotype DX Genomic Prostate Score - Understanding the Results

What your patients can prepare for prior to an appointment with you to discuss their Oncotype DX Genomic Prostate Score results. Learn more about interpreting the GPS report results


Additional Resources

Download Patient Brochure
Patient Brochure

A guide to the Oncotype DX GPS for men newly diagnosed with early-state prostate cancer.

Download Patient Report Overview
Patient Report Overview

A guide to understanding Oncotype DX GPS test results.

Download Genetics vs Genomics
Genetics vs. Genomics

A summary of what questions genetic and genomic tests may answer.

Download Active Surveillance Infographic
Active Surveillance Infographic

A visual representation of the importance of active surveillance as a treatment option.

Making cancer care smarter.™
X

We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.